The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00184171
(insufficient data quality)
The study compares the effect of Budesonide, Bismuth and fiber in patients with microscopic colitis
Condition or disease
Drug: BudesonideDrug: BismuthDrug: Fiber
This randomized, controlled, open study compares the effects of 8 weeks' treatment with Budesonide, Bismuth and fiber on symptoms and histological findings in patients with microscopic colitis (both collagenous colitis and lymphocytic colitis).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Microscopic colitis verified with biopsies from the colon
Symptoms to such an extent that treatment is indicated
Age > 17 years
Previous treatment with any of the investigational drugs